Candel Therapeutics Statistics

Total Valuation

CADL has a market cap or net worth of $233.98 million. The enterprise value is $152.73 million.

Market Cap	233.98M
Enterprise Value	152.73M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, before market open.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

CADL has 50.10 million shares outstanding. The number of shares has increased by 27.55% in one year.

Current Share Class	50.10M
Shares Outstanding	50.10M
Shares Change (YoY)	+27.55%
Shares Change (QoQ)	+53.99%
Owned by Insiders (%)	8.02%
Owned by Institutions (%)	45.78%
Float	42.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.08
P/TBV Ratio	3.13
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.64, with a Debt / Equity ratio of 0.15.

Current Ratio	4.64
Quick Ratio	4.59
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-18.78

Financial Efficiency

Return on equity (ROE) is -98.14% and return on invested capital (ROIC) is -36.46%.

Return on Equity (ROE)	-98.14%
Return on Assets (ROA)	-32.31%
Return on Invested Capital (ROIC)	-36.46%
Return on Capital Employed (ROCE)	-43.33%
Revenue Per Employee	n/a
Profits Per Employee	-$1.04M
Employee Count	38
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.68% in the last 52 weeks. The beta is -0.87, so CADL's price volatility has been lower than the market average.

Beta (5Y)	-0.87
52-Week Price Change	-22.68%
50-Day Moving Average	5.18
200-Day Moving Average	6.47
Relative Strength Index (RSI)	35.85
Average Volume (20 Days)	909,469

Short Selling Information

The latest short interest is 5.89 million, so 11.75% of the outstanding shares have been sold short.

Short Interest	5.89M
Short Previous Month	6.22M
Short % of Shares Out	11.75%
Short % of Float	14.01%
Short Ratio (days to cover)	6.06

Income Statement

Revenue	n/a
Gross Profit	-18.13M
Operating Income	-32.86M
Pretax Income	-37.37M
Net Income	-39.58M
EBITDA	-31.87M
EBIT	-32.86M
Earnings Per Share (EPS)	-$1.08

Full Income Statement

Balance Sheet

The company has $92.17 million in cash and $10.91 million in debt, giving a net cash position of $81.25 million or $1.62 per share.

Cash & Cash Equivalents	92.17M
Total Debt	10.91M
Net Cash	81.25M
Net Cash Per Share	$1.62
Equity (Book Value)	74.68M
Book Value Per Share	1.52
Working Capital	73.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$27.20 million and capital expenditures -$12,000, giving a free cash flow of -$27.21 million.

Operating Cash Flow	-27.20M
Capital Expenditures	-12,000
Free Cash Flow	-27.21M
FCF Per Share	-$0.54

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CADL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.55%
Shareholder Yield	-27.55%
Earnings Yield	-16.91%
FCF Yield	-11.63%

Analyst Forecast

The average price target for CADL is $21.00, which is 349.68% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.00
Price Target Difference	349.68%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3